NCT05899790

Brief Summary

Virtual Reality (VR) applications, one of the commonly emphasized approaches in the medical field recently, is in place as an intervention method applicable in various fileds of medicine for distraction, experiencing being exposed to events creating stress and palliating anxiety through providing materials which may distract the patient's attention from a stressful condition. The study has been planned in order to evaluate the effect of the notification regarding the theatre environment through virtual reality to the patients, who are to go through abdominal surgical intervention, on the anxiety level and the vital signs during the surgical intervention. Being a non-pharmacological clinical randomize controlled one, the study shall be conducted in Dr. Burhan Nalbantoğlu State Hospital of TRNC Ministry of Health surgical service and preoperative waiting area. Sample number has been determined through power analysis using G\*Power 3.1.9.2 software. Taking (2017) "The effect of virtual reality in reducing preoperative anxiety in patients prior to arthroscopic knee surgery: A randomised controlled trial" study of Robertson and friends as the reference, the effect size, regarding the anxiety scores of experiment and control groups participants, has been determined as 0,63. Accordingly, sample size has been calculated as 71 people necessary for 95% (1-β=0,95) power at d=0,63 and α=0,05 levels. Taking into account there may be losses during the study, it has been planned to involve 80 people, so as to have 40 people per each group, in the study. Since the patients, who are to be involved in the study, are not known; in order to assign same quantity of patients to each group prior to the study, randomization shall be done through using block randomization technique in GraphPad software so as to have 40 patients in the intervention group and 40 in the control group. The patients who receive standard clinical care prior to abdominal surgical intervention shall constitute the control group, the patients who receive information about operating room environment through VR goggles in addition to standard clinical care shall constitute the intervention group. The data shall be collected through "Individual characteristics Form", ''Patient Charts'', ''Surgical Anxiety Scale'', ''Galvanic Skin Sensor (GSS) Measurement Table''. SPSS 26 Statistical analysis program shall be used for evaluating the study data. The acquired data shall be tested at 95% confidence interval, p\<0,05 level of significance. Number, percentage distributon and standard deviation for the definitive data analysis, chi square test for experiment and control groups' basic particulars similarity, Shapiro-Wilk for normality analysis of dependent variables, Student t test or Annova for the comparison of pre-test and final test scores of experiment control groups, the comparisons of variables giving normal distribution among the groups as per the normal distributon in the comparison of experiment control groups' pre-test and final test scores, Mann Whitney U test or Kruskal Wallis test for the variables of non-normal distribution shall be used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

June 29, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2022

Completed
6 months until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
Last Updated

June 12, 2023

Status Verified

June 1, 2023

Enrollment Period

5 months

First QC Date

March 30, 2022

Last Update Submit

June 9, 2023

Conditions

Keywords

Preoperative anxiety,virtual reality,abdominal surgery,information about the operating room environment

Outcome Measures

Primary Outcomes (1)

  • Surgical Anxiety Scale

    maximum: 4 minimum: 0

    two day

Study Arms (2)

Control Group

NO INTERVENTION

Forty patients who received standard care in the pre-abdominal surgery clinic and preoperative waiting area will form the control group.

intervention group

EXPERIMENTAL

In addition to standard care, 40 patients who were informed about the SG application and the operating room environment will form the intervention group.

Other: VR

Interventions

VROTHER

The first interview with the patients in the intervention group will be held in the afternoon, the day before the surgery. After completing the forms and scale the video containing information about the operating room environment will be applied to the patients through SG glasses and headphones. Before the surgical intervention, patients admitted to the pre-operative waiting area from the clinic, the video containing information about the operating room environment will be watched by the patients through SG glasses and headphones.

Also known as: Virtual reality
intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • who are of 18 years old and over,
  • are to go through abdominal surgical intervention,
  • are conscious, have orientation of place-person and time,
  • do not have any visual,
  • audial or mental problem,
  • have the ability of understanding the instructions of the study and reacting,
  • can communicate in Turkish
  • and give written approval for participating in the study

You may not qualify if:

  • the patients who regularly receive phytotherapy or pharmacotherapy for anxiety,
  • are diagnosed with hypertension,
  • cardiac arrhythmia,
  • have facial injuries preventing comfortable utilization of VR hardware
  • and are unpremedicated.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Doğu Akdeniz Üniversitesi

Famagusta, 99450, Cyprus

Location

Study Officials

  • serpil çağlıyan payas, lecturer

    DOĞU AKDENİZ ÜNİVERSİTESİ

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: 2 Group 1. İntervention 2. Control
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

March 30, 2022

First Posted

June 12, 2023

Study Start

June 29, 2022

Primary Completion

November 15, 2022

Study Completion

December 15, 2022

Last Updated

June 12, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Clinical Study Report Access
Clinical Study Report Access
Clinical Study Report Access

Locations